Added to YB: 2025-04-23
Pitch date: 2025-04-21
4BB.L [neutral]
4basebio PLC
-59.11%
current return
Author Info
Increasing Odds shares their investment journey in their newsletter. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally.
Market Cap
GBP 81.6M
Pitch Price
GBP 11.25
Price Target
N/A
Dividend
N/A
EV/EBITDA
-5.13
P/E
-4.82
EV/Sales
47.40
Sector
Biotechnology
Category
N/A
Show full summary:
Exploring AIM: A-Z Part 1 - 4basebio PLC
4BB.L pass: £180M unprofitable biotech at >100x sales. Recent catalysts: UK manufacturing certification, new CCO appointed, RBC coverage initiated. Something's happening but biotech knowledge needed.
Read full article (1 min)